Literature DB >> 20713817

Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease.

Aimee C Smidt1, Jin-Shei Lai, David Cella, Sapna Patel, Anthony J Mancini, Sarah L Chamlin.   

Abstract

OBJECTIVE: To develop and validate a quality-of-life index for adolescents with skin disease.
DESIGN: Prospective, longitudinal cohort study taking place from July 15, 2005, through February 29, 2008.
SETTING: Academic pediatric dermatology practice. PATIENTS: A total of 205 patients between the ages of 12 and 17 years with a skin condition. MAIN OUTCOME MEASURES: Participants completed the Skindex-Teen questionnaire, reported sociodemographic data, and answered clinical questions at enrollment. Four weeks later, they completed Skindex-Teen and responded to clinical questions again. Forty patients also completed Skindex-Teen 48 hours after baseline.
RESULTS: Of 205 patients, 200 (97.6%) completed all enrollment materials; 125 (62.5%) of these returned follow-up materials, of which 115 (57.5%) were complete. Twenty-three of 40 participants (57.5%) completed the 48-hour-after-initial-answers materials. The mean (SD) age of the patients was 15.3 (1.4) years (range, 12.9-18.0 years). Approximately half reported their skin condition as poor (26 [13.0%]) or fair (67 [33.5%]); most rated their general health as very good (62 [31.0%]) or excellent (80 [40.0%]). The dimensionality of the items was evaluated using factor analysis; results suggested 2 factors, termed physical symptoms (5 items) and psychosocial functioning (16 items). Both scales demonstrated excellent internal consistency. All item-scale reliabilities were greater than 0.4. Fit of items to the measurement model was supported by Rasch analysis. Test-retest reliability was supported by intraclass correlation coefficients (0.82-0.94) for total scores, physical symptoms, and psychosocial functioning scales. At 4 weeks, 16 (13.9%) reported worsening of their skin condition, 57 (19.6%) reported it had remained unchanged, and 42 (36.5%) reported improvement. Significant mean differences were present between the improved and worsened groups for the psychosocial functioning scale and total scores.
CONCLUSIONS: These data provide evidence of construct, content, and face validity for Skindex-Teen, a new quality-of-life instrument for adolescents with skin disease. Test-retest reliability was verified, and responsiveness at 4 weeks was shown for total scores and the psychosocial functioning scale scores.

Entities:  

Mesh:

Year:  2010        PMID: 20713817     DOI: 10.1001/archdermatol.2010.161

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  9 in total

Review 1.  The Skindex instruments to measure the effects of skin disease on quality of life.

Authors:  Mary-Margaret Chren
Journal:  Dermatol Clin       Date:  2011-12-20       Impact factor: 3.478

Review 2.  Application of Rasch Analysis for Development and Psychometric Properties of Adolescents' Quality of Life Instruments: A Systematic Review.

Authors:  Sahar Dabaghi; Fatemeh Esmaielzadeh; Camelia Rohani
Journal:  Adolesc Health Med Ther       Date:  2020-11-11

Review 3.  Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Sarah L Chamlin; Steven R Feldman; Jon M Hanifin; Eric L Simpson; Timothy G Berger; James N Bergman; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Alfons Krol; David J Margolis; Amy S Paller; Kathryn Schwarzenberger; Robert A Silverman; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2013-11-27       Impact factor: 11.527

4.  Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review.

Authors:  Hayley Smith; Alison M Layton; Diane Thiboutot; Abbey Smith; Heather Whitehouse; Waseem Ghumra; Meenakshi Verma; Jerry Tan; Georgina Jones; Kathryn Gilliland; Megha Patel; Elaine Otchere; Anne Eady
Journal:  Am J Clin Dermatol       Date:  2021-03       Impact factor: 7.403

5.  Family burden in inherited ichthyosis: creation of a specific questionnaire.

Authors:  Hélène Dufresne; Smail Hadj-Rabia; Cécile Méni; Vincent Sibaud; Christine Bodemer; Charles Taïeb
Journal:  Orphanet J Rare Dis       Date:  2013-02-15       Impact factor: 4.123

6.  Development and preliminary validation of the Adolescent Psoriasis Quality of Life instrument: a disease-specific measure of quality of life in adolescents with psoriasis.

Authors:  H Randa; L R Khoury; T K Grønborg; J J Lomholt; L Skov; R Zachariae
Journal:  Br J Dermatol       Date:  2020-01-29       Impact factor: 9.302

7.  Safety and efficacy of topical, fixed-dose combination calcipotriene (0.005%) and betamethasone (0.064% as dipropionate) gel in adolescent patients with scalp and body psoriasis: a phase II trial.

Authors:  L F Eichenfield; D Marcoux; M Kurvits; M Liljedahl
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-01-02       Impact factor: 6.166

Review 8.  Quality of Life and Disease Impact of Atopic Dermatitis and Psoriasis on Children and Their Families.

Authors:  Chan Ho Na; Janice Chung; Eric L Simpson
Journal:  Children (Basel)       Date:  2019-12-02

9.  Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.

Authors:  Pamela L Wolters; Ana-Maria Vranceanu; Heather L Thompson; Staci Martin; Vanessa L Merker; Andrea Baldwin; Carolina Barnett; Kimberley S Koetsier; Cynthia M Hingtgen; Christopher J Funes; James H Tonsgard; Elizabeth K Schorry; Taryn Allen; Taylor Smith; Barbara Franklin; Stephanie Reeve
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.